TCW Group’s AstraZeneca AZN Stock Holding History

TCW Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.7M	Sell	142,573 -349	-0.2%	-$65.6K	0.18%	108
2026 Q1	$27.7M	Buy	+142,922	New	+$27.6M	0.21%	100
2019 Q1	–	Sell	-23,010	Closed	-$1.75M	–	315
2018 Q4	$1.75M	Buy	23,010 +205	+0.9%	+$16K	0.02%	226
2018 Q3	$1.8M	Buy	22,805 +3,330	+17%	+$252K	0.01%	234
2018 Q2	$1.37M	Buy	19,475 +5,425	+39%	+$390K	0.01%	248
2018 Q1	$983K	Buy	14,050 +925	+7%	+$64.1K	0.01%	272
2017 Q4	$911K	Hold	13,125	–	–	0.01%	281
2017 Q3	$889K	Hold	13,125	–	–	0.01%	292
2017 Q2	$895K	Hold	13,125	–	–	0.01%	292
2017 Q1	$817K	Hold	13,125	–	–	0.01%	309
2016 Q4	$717K	Hold	13,125	–	–	0.01%	566
2016 Q3	$863K	Hold	13,125	–	–	0.01%	512
2016 Q2	$792K	Hold	13,125	–	–	0.01%	535
2016 Q1	$739K	Sell	13,125 -425	-3%	-$25.5K	0.01%	559
2015 Q4	$920K	Hold	13,550	–	–	0.01%	513
2015 Q3	$862K	Sell	13,550 -4,300	-24%	-$283K	0.01%	546
2015 Q2	$1.14M	Hold	17,850	–	–	0.01%	501
2015 Q1	$1.22M	Sell	17,850 -1,400	-7%	-$97.3K	0.01%	691
2014 Q4	$1.35M	Buy	19,250 +1,700	+10%	+$122K	0.01%	669
2014 Q3	$1.25M	Hold	17,550	–	–	0.01%	692
2014 Q2	$1.3M	Hold	17,550	–	–	0.01%	692
2014 Q1	$1.14M	Sell	17,550 -17,650	-50%	-$1.14M	﹤0.01%	706
2013 Q4	$2.09M	Hold	35,200	–	–	0.01%	663
2013 Q3	$1.83M	Hold	35,200	–	–	0.01%	673
2013 Q2	$1.67M	Buy	+35,200	New	+$1.79M	0.01%	659

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TCW Group's AZN Position: Q2 2026 in Review

TCW Group reduced its AstraZeneca (AZN) stake by 0.24% in Q2 2026, selling an estimated $65.6K and leaving 142,573 shares worth $26.7M. The position accounts for 0.18% of the portfolio, ranked #108.

TCW Group first reported a position in AZN in Q2 2013 and has held it in 25 quarters since. The position peaked at $27.7M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

TCW Group held 142,573 shares of AstraZeneca worth $26.7M as of Q2 2026.
TCW Group sold 349 AstraZeneca shares in Q2 2026, an estimated $65.6K.
AstraZeneca made up 0.18% of TCW Group's portfolio in Q2 2026, its #108 holding.
TCW Group first reported a position in AstraZeneca in Q2 2013 and has held it in 25 quarters since.
TCW Group's AstraZeneca position peaked at $27.7M in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.